Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Dr Karyn Maclennan

PositionResearch Fellow
DepartmentDepartment of Preventive and Social Medicine (Dunedin)
Research summarySafe and optimal use of medicines, medicines communication, Māori health, health equity

Research

Karyn has a background in pharmacology and psychology, has worked broadly across pharmaceutical medicine in New Zealand and the UK and is a member of the Pharmacoepidemiology Research Network Core Academic Group.

She has a strong interest in public outreach and communication about medicines, Māori health, health inequities, and partnering with community groups to collaborate on locally relevant research projects. Her current research includes:

  • Interactive public outreach about the science of medicines, which aims to empower children and their whānau to have confident discussions and make informed, shared, and positive decisions about medicines
  • A participatory science project with Cystic Fibrosis Otago investigating safe disposal of antibiotic residue in nebulisers
  • Exploring the supportive care needs of Māori cancer survivors
  • Exploring whānau acceptability of CovidCard contact tracing technology in the Ngongotahā CovidCard trial

Publications

Parkin, L., Maclennan, K., Te Morenga, L., Inder, M., & Moata'ane, L. (2021). What helps and hinders metformin adherence and persistence: A qualitative study exploring the views of people with type 2 diabetes. New Zealand Medical Journal, 134(1536), 25-40. Retrieved from https://www.nzma.org.nz/journal

Maclennan, K., Brounéus, F., & Parkin, L. (2016). Public knowledge and desire for knowledge about drug safety issues: A survey of the general public in New Zealand. Pharmaceutical Medicine, 30(6), 339-348. doi: 10.1007/s40290-016-0164-4

Brounéus, F., Macleod, G., Maclennan, K., Parkin, L., & Paul, C. (2012). Drug safety awareness in New Zealand: Public knowledge and preferred sources for information. Journal of Primary Health Care, 4(4), 288-293.

Maclennan, K. M., Zheng, Y., Sheard, P. W., Williams, S. M., Darlington, C. L., & Smith, P. F. (2003). Adrenalectomy-induced cell death in the dentate gyrus: Further characterisation using TUNEL and effects of the Ginkgo biloba extract, EGb 761 and ginkgolide B. Hippocampus, 13, 212-225.

Maclennan, K. M., Darlington, C. L., & Smith, P. F. (2002). The CNS effects of Ginkgo biloba extracts and ginkgolide B. Progress in Neurobiology, 67, 235-257.

Darlington, C. L., Smith, P. F., & Maclennan, K. M. (1999). The neuroprotective properties of ginkgo extracts. In T. A. Van Beek (Ed.), Medicinal and Aromatic Plants - Industrial Profiles: Ginkgo Biloba. (pp. 331-344). Amsterdam: Harwood Academic Publishers.

Chapter in Book - Research

Darlington, C. L., Smith, P. F., & Maclennan, K. M. (1997). Effects of Ginkgo biloba extract (EGb 761) on recovery from peripheral vestibular deafferentation (vestibular compensation). In V. Papadopoulos, K. Drieu & Y. Christen (Eds.), Advances in Ginkgo biloba Research, Vol. 6. (pp. 47-58). Paris: Elsevier.

Chapter in Book - Research

Parkin, L., Maclennan, K., Te Morenga, L., Inder, M., & Moata'ane, L. (2021). What helps and hinders metformin adherence and persistence: A qualitative study exploring the views of people with type 2 diabetes. New Zealand Medical Journal, 134(1536), 25-40. Retrieved from https://www.nzma.org.nz/journal

Journal - Research Article

Maclennan, K., Brounéus, F., & Parkin, L. (2016). Public knowledge and desire for knowledge about drug safety issues: A survey of the general public in New Zealand. Pharmaceutical Medicine, 30(6), 339-348. doi: 10.1007/s40290-016-0164-4

Journal - Research Article

Brounéus, F., Macleod, G., Maclennan, K., Parkin, L., & Paul, C. (2012). Drug safety awareness in New Zealand: Public knowledge and preferred sources for information. Journal of Primary Health Care, 4(4), 288-293.

Journal - Research Article

Maclennan, K. M., Zheng, Y., Sheard, P. W., Williams, S. M., Darlington, C. L., & Smith, P. F. (2003). Adrenalectomy-induced cell death in the dentate gyrus: Further characterisation using TUNEL and effects of the Ginkgo biloba extract, EGb 761 and ginkgolide B. Hippocampus, 13, 212-225.

Journal - Research Article

Maclennan, K. M., Darlington, C. L., & Smith, P. F. (2002). The CNS effects of Ginkgo biloba extracts and ginkgolide B. Progress in Neurobiology, 67, 235-257.

Journal - Research Article

Smith, P. F., & Maclennan, K. M. (1999). The neuroprotective effects of platelet activating factor (PAF) receptor antagonists in CNS disorders. Current Opinion in Anti-inflammatory & Immunomodulatory Investigational Drugs, 1, 205-218.

Journal - Research Article

Paul, C. A., Sansom, A. J., Maclennan, K., Darlington, C. L., & Smith, P. F. (1998). The effects of steroids on vestibular compensation and vestibular nucleus neuronal activity in guinea pig. Journal of Vestibular Research, 8(3), 201-207.

Journal - Research Article

Maclennan, K. M., Smith, P. F., & Darlington, C. L. (1996). Platelet-activating factor in the CNS. Progress in Neurobiology, 50(5-6), 585-596.

Journal - Research Article

Maclennan, K., Smith, P. F., & Darlington, C. L. M. (1996). The effects of ginkgolide B (BN52021) on guinea pig vestibular nucleus neurons in vitro: importance of controlling for effects of dimethylsulphoxide (DMSO) vehicles. Neuroscience Research, 26(4), 395-399.

Journal - Research Article

Smith, P. F., Darlington, C. L., & Maclennan, K. (1995). Ginko Biloba: An ancient Chinese tree with neuroprotective properties. Asia Pacific Journal of Pharmacology, 10, 3-4.

Journal - Research Article

More publications...